TY - JOUR
T1 - Predicting Periprocedural Complications in Chronic Total Occlusion Percutaneous Coronary Intervention
T2 - The PROGRESS-CTO Complication Scores
AU - Simsek, Bahadir
AU - Kostantinis, Spyridon
AU - Karacsonyi, Judit
AU - Alaswad, Khaldoon
AU - Krestyaninov, Oleg
AU - Khelimskii, Dmitrii
AU - Davies, Rhian
AU - Rier, Jeremy
AU - Goktekin, Omer
AU - Gorgulu, Sevket
AU - ElGuindy, Ahmed
AU - Chandwaney, Raj H.
AU - Patel, Mitul
AU - Abi Rafeh, Nidal
AU - Karmpaliotis, Dimitrios
AU - Masoumi, Amirali
AU - Khatri, Jaikirshan J.
AU - Jaffer, Farouc A.
AU - Doshi, Darshan
AU - Poommipanit, Paul B.
AU - Rangan, Bavana V.
AU - Sanvodal, Yader
AU - Choi, James W.
AU - Elbarouni, Basem
AU - Nicholson, William
AU - Jaber, Wissam A.
AU - Rinfret, Stephane
AU - Koutouzis, Michael
AU - Tsiafoutis, Ioannis
AU - Yeh, Robert W.
AU - Burke, M. Nicholas
AU - Allana, Salman
AU - Mastrodemos, Olga C.
AU - Brilakis, Emmanouil S.
N1 - Publisher Copyright:
© 2022 American College of Cardiology Foundation
PY - 2022/7/25
Y1 - 2022/7/25
N2 - Background: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with increased risk of periprocedural complications. Estimating the risk of complications facilitates risk-benefit assessment and procedural planning. Objectives: This study sought to develop risk scores for in-hospital major adverse cardiovascular events (MACE), mortality, pericardiocentesis, and acute myocardial infarction (MI) in patients undergoing CTO PCI. Methods: The study analyzed the PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention; NCT02061436) and created risk scores for MACE, mortality, pericardiocentesis, and acute MI. Logistic regression prediction modeling was used to identify independently associated variables, and models were internally validated with bootstrapping. Results: The incidence of periprocedural complications among 10,480 CTO PCIs was as follows: MACE 215 (2.05%), mortality 47 (0.45%), pericardiocentesis 83 (1.08%), and acute MI 66 (0.63%). The final model for MACE included ≥65 years of age (1 point), moderate-severe calcification (1 point), blunt stump (1 point), antegrade dissection and re-entry (ADR) (1 point), female (2 points), and retrograde (2 points); the final model for mortality included ≥65 years of age (1 point), left ventricular ejection fraction ≤45% (1 point), moderate-severe calcification (1 point), ADR (1 point), and retrograde (1 point); the final model for pericardiocentesis included ≥65 years of age (1 point), female (1 point), moderate-severe calcification (1 point), ADR (1 point), and retrograde (2 points); the final model for acute MI included prior coronary artery bypass graft surgery (1 point), atrial fibrillation (1 point), and blunt stump (1 point). The C-statistics of the models were 0.74, 0.80, 0.78, 0.72 for MACE, mortality, pericardiocentesis, and acute MI, respectively. Conclusions: The PROGRESS-CTO complication risk scores can facilitate estimation of the periprocedural complication risk in patients undergoing CTO PCI.
AB - Background: Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with increased risk of periprocedural complications. Estimating the risk of complications facilitates risk-benefit assessment and procedural planning. Objectives: This study sought to develop risk scores for in-hospital major adverse cardiovascular events (MACE), mortality, pericardiocentesis, and acute myocardial infarction (MI) in patients undergoing CTO PCI. Methods: The study analyzed the PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention; NCT02061436) and created risk scores for MACE, mortality, pericardiocentesis, and acute MI. Logistic regression prediction modeling was used to identify independently associated variables, and models were internally validated with bootstrapping. Results: The incidence of periprocedural complications among 10,480 CTO PCIs was as follows: MACE 215 (2.05%), mortality 47 (0.45%), pericardiocentesis 83 (1.08%), and acute MI 66 (0.63%). The final model for MACE included ≥65 years of age (1 point), moderate-severe calcification (1 point), blunt stump (1 point), antegrade dissection and re-entry (ADR) (1 point), female (2 points), and retrograde (2 points); the final model for mortality included ≥65 years of age (1 point), left ventricular ejection fraction ≤45% (1 point), moderate-severe calcification (1 point), ADR (1 point), and retrograde (1 point); the final model for pericardiocentesis included ≥65 years of age (1 point), female (1 point), moderate-severe calcification (1 point), ADR (1 point), and retrograde (2 points); the final model for acute MI included prior coronary artery bypass graft surgery (1 point), atrial fibrillation (1 point), and blunt stump (1 point). The C-statistics of the models were 0.74, 0.80, 0.78, 0.72 for MACE, mortality, pericardiocentesis, and acute MI, respectively. Conclusions: The PROGRESS-CTO complication risk scores can facilitate estimation of the periprocedural complication risk in patients undergoing CTO PCI.
KW - MACE
KW - acute myocardial infarction
KW - chronic total occlusion
KW - mortality
KW - percutaneous coronary intervention
KW - pericardiocentesis
KW - risk prediction
UR - http://www.scopus.com/inward/record.url?scp=85133859506&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133859506&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2022.06.007
DO - 10.1016/j.jcin.2022.06.007
M3 - Article
C2 - 35863789
AN - SCOPUS:85133859506
SN - 1936-8798
VL - 15
SP - 1413
EP - 1422
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 14
ER -